Survival estimates from the Cox proportional hazards model also favored arimoclomol compared to control, with an unadjusted hazard ratio (HR) of 0.67 (95% CI 0.29–1.48, p = 0.33);
arimoclomol 200 mg
placebo
Survival estimates